NABL, CAP, ISO
Overview of Bilirubin (Total, Direct and Indirect)
What is Bilirubin (Total, Direct and Indirect)?
It is usually ordered when you have signs or symptoms of liver damage, liver disease like jaundice, dark urine, nausea, vomiting; when you have evidence of bile duct blockage or hemolytic anemia. Sometimes, it is also ordered in newborns with jaundice.
Why is Bilirubin (Total, Direct and Indirect) done?
- If you have signs or symptoms of liver disease like dark colored urine, jaundice, nausea, vomiting, abdominal pain, fatigue
- As a part of liver function test or routine health check up
- If you have a history of taking excess amounts of alcohol
- If you have been exposed to hepatitis causing virus
- If you have symptoms or signs of hemolytic anemia like pale skin, jaundice, splenomegaly
- In newborns, to monitor neonatal jaundice
Preparation for Bilirubin (Total, Direct and Indirect)
- No special preparation required
Sample Type for Bilirubin (Total, Direct and Indirect)
The sample type collected for Bilirubin (Total, Direct and Indirect) is: Blood
Interpreting Bilirubin (Total, Direct and Indirect) results
- Increased total bilirubin which is mainly unconjugated may be due to hemolytic anemia, transfusion reactions
- Increased total bilirubin which is mainly conjugated may be due to viral hepatitis, drug reactions, alcoholic liver disease, gall stones or any obstruction in the bile ducts
- Low levels of bilirubin are usually not a cause for concern and therefore not monitored
Tests Included in Bilirubin (Total, Direct and Indirect)(3 tests)
- Bilirubin Direct
- Bilirubin Indirect
We focus on providing patients quality diagnostic healthcare services in India. Through our network, we offer patients convenient locations for their diagnostic healthcare services and efficient service. With over 3368 diagnostic and related healthcare tests and services offered, we believe we are capable of performing substantially all of the diagnostic healthcare tests and services currently prescribed by physicians in India. Our key competitive strengths are: Business model focused on the patient as a customer and an established consumer healthcare brand associated with quality services, in a market where patients generally choose their diagnostic healthcare service provider. Well-positioned to leverage upon one of the fastest-growing segments of the Indian healthcare industry. A network whose growth yields greater economies of scale, combined with a hub and spoke model that is scalable for further growth. Centralized information technology platform that fully integrates our network and is scalable. Attractive financial performance, financial profile and return on invested capital. Experienced leadership team with strong industry expertise and successful track record. Some of our laboratories have achieved International Organization for Standardization, or ISO, certification for their quality systems. Our National Reference Laboratory has obtained ISO 9001:2008 certification (for the performance of routine and advanced diagnostic pathology testing services, including clinical trials), ISO 15189:2007 (for quality management in medical laboratories), ISO 15189:2012 certification (in the field of medical testing) and ISO 27001:2013 certification (for establishing an effective information management system that maintains and processes information security at our data center).